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Purpose	There is much evidence-based research proving the effectiveness of contrast echocardiography, but
there are still questions and concerns about its specific uses. This study tested the effectiveness of
contrast echocardiography in defining the left ventricular endocardial border.
Methods	
From 30 patients, a total of 60 echocardiograms –– 30 with and 30 without use of contrast –– were
retrospectively reviewed by four blinded cardiologists with advanced training in echocardiography.
No single cardiologist reviewed contrast and noncontrast images of the same patient. Each set of
30 echocardiograms was then studied for wall-motion scoring. Visualization of left ventricular wall
segments and a global visualization confidence level of interpretation were recorded.
Results		Of all wall segments (N=510), 91% were visualized in echocardiograms with use of contrast, whereas
75% of the walls were visualized in echocardiograms without contrast (P<0.001). Of 30 examinations, 17
contrast echocardiograms were read with high confidence compared to 6 without contrast use (P=0.004).
The number of walls visualized with contrast was increased in 18 patients (60%), whereas noncontrast
echocardiograms yielded more visualized walls in 6 patients (20%, P=0.002).
Conclusions	
This study demonstrates that contrast is valuable to echocardiographic imaging. Its use should be
supported throughout echocardiography clinics and encouraged in certain patients for whom resting
and stress echocardiography results without contrast often prove uninterpretable. (J Patient-Centered
Res Rev. 2016;3:40-47.)
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Echocardiography is the test most performed for
evaluation of cardiac function. In patients for whom
obtaining clear ultrasound images of the heart is
considered technically difficult, such as those with
obesity or lung disease,1 contrast echocardiography
improves visualization.2 Contrast agents improve
image quality and endocardial border definition, which
is important in assessing heart function (particularly
when identifying abnormalities3). Currently the most
common applications of contrast echocardiography are:
1) to opacify the left ventricle (LV), and 2) to enhance
endocardial border delineation.4 LV opacification is
the approved indication for contrast agents5 because
accurate measurements of LV function provide
valuable diagnostic and prognostic information.6
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Accurately delineating endocardial borders leads
to reduced variability and increases accuracy in LV
volume and ejection fraction measurements.1
Despite the proven diagnostic benefits of contrast
echocardiography, use of contrast agents is not a
common practice in clinical laboratories.7,8 Many
labs and hospitals are reluctant to use contrast due to
perceived issues of cost, effect on examination time,
misuse and, more recently, questions concerning its
safety.7,9 The purpose of this report is twofold. First,
we present our study of the effectiveness of contrast
echocardiography in defining the LV endocardial
border as further evidence that contrast should be used
routinely on technically difficult patients in whom
noncontrast echocardiography produces inadequate
image quality and therefore insufficient information
to make an accurate diagnosis. Second, we discuss the
added value and the controversies regarding the use of
contrast in echocardiography.
Original Research

METHODS

Research Participants
This study was approved by the local institutional
review board. The research subject population included
a sampling of adult patients for whom use of a contrast
agent was clinically indicated. Contrast is clinically
indicated for endocardial border detection and LV
opacification when at least 2 out of 17 wall segments
of the LV are not well visualized. It is also indicated for
Doppler enhancement, thrombus detection and patients
who have suboptimal stress echocardiographic images
as determined by the institution’s contrast policy.1
Our institution’s cardiologists created a standing order
that use of contrast would be at the sonographer’s
discretion, with or without physician approval,
during the time of examination. Echocardiograms
and contrast administration were performed by a
single American Registry for Diagnostic Medical
Sonography (ARDMS)-credentialed sonographer to
eliminate variability in the use of contrast as well

as limit the differences in contrast administration
technique and machine parameters used. Of all 30
patients included in this investigation, no side effects
from use of contrast were documented.
Sampling Method
Thirty clinically indicated contrast echocardiograms
from May 2011 to July 2011 were randomly selected
for review. Gender and age were not indications for
study inclusion or exclusion. LV images with and
without use of contrast were obtained from each
patient’s echocardiogram. Parasternal images of the
LV from the long and short axes with and without use
of contrast (Figures 1 and 2; Online Videos 1–4) as
well as apical images of the four- and two-chamber
views with and without use of contrast (Figures 3 and
4; Online Videos 5–8) were obtained from each patient.
Contrast and noncontrast images of each patient were
separated to create 60 examinations (30 noncontrast,
30 contrast), each consisting of four images (long-axis,
short-axis, two-chamber and four-chamber views).

Figure 1.

Echocardiography
in the parasternal
long-axis view
without (A) and
with (B) contrast in
a sample patient.

Figure 2.

Echocardiography
in the parasternal
short-axis view
without (A) and
with (B) contrast in
the same patient
as Figure 1.
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Figure 3.

Echocardiography
in the apical fourchamber view
without (A) and
with (B) contrast in
the same patient
as Figure 1.

Figure 4.

Echocardiography
in the apical twochamber view
without (A) and
with (B) contrast in
the same patient
as Figure 1.

Four cardiologists who had Level III training in
echocardiography, the highest level per the Core
Cardiology Training Symposium training guidelines,10
were asked to define the LV segments in each image.
LV segmental visualization was the main variable
measured. All patient identifiers were deleted from
the images to generate a blinded study for the reading
cardiologists. To further reduce potential for bias, no
cardiologist read both the contrast and noncontrast
images of the same patient.
Instruments used to obtain this study sample beyond
physician and sonographer contrast protocols
and procedures were ProSolv® software (ProSolv
Cardiovascular, Indianapolis, IN), contrast agent
Definity® (Lantheus Medical Imaging, North Billerica,
MA), Vialmix™ shaker (Bristol-Myers Squibb Medical
Imaging, North Billerica, MA), three different brands
of echocardiography machines (Vivid E9™, GE
Healthcare, Waukesha, WI; iE33 xMATRIX™, Philips
Healthcare, Best, The Netherlands; and Artida™,
Toshiba Medical Systems, Tochigi, Japan), and MAC
Numbers spreadsheet program (Apple Inc., Cupertino,
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CA) for data analysis. All three echocardiography
machines carry updated and advanced contrast package
software that includes adequate settings for obtaining
optimal contrast images.
Definity is a nonblood-based ultrasound contrast
approved by the U.S. Food and Drug Administration
(FDA). The Definity product contains components that,
upon activation, yield perflutren lipid microspheres, a
diagnostic drug that is intended to be used for contrast
enhancement during indicated echocardiographic
procedures. The suspension of activated Definity is
administered by intravenous injection. After activation
and injection, the physical acoustic properties of
activated Definity provide contrast enhancement of
the endocardial borders during echocardiography
(2011 package insert, Bristol-Myers Squibb Medical
Imaging). The dilution method was used to administer
contrast in our sample echocardiograms.
Statistical Analysis
All data was analyzed with a two-proportion Z-test.
Physician scores of the 17 LV wall segments (per

Original Research

American Society of Echocardiography’s 17-segment
model) were collected. Degree of physician
confidence in the overall global visualization of the
17 segments, including ability to interpret wall motion
throughout the endocardial border, was recorded
for each examination. Adequacy of overall global
visualization was graded by each physician as: No
confidence in overall visualization; Low confidence
in overall visualization; or High confidence in overall
visualization. High confidence was interpreted as the
best possible examination accuracy. While these grades
were subjectively determined by each physician, and
therefore open to bias, making a judgment on the overall
strength of the examination reflects standard clinical
decision-making and provides a real-world setting to
compare results from contrast and noncontrast images.

RESULTS

Endocardial Border Visualization
Of the 510 total wall segments in all 30 patients, 462
(91%) were visualized with use of contrast and 383
(75%) visualized without use of contrast (Figure 5).
A two-proportion Z-test comparing endocardial border
visualization with and without contrast revealed a
statistically significant improvement in endocardial
border visualization after contrast administration
(Z=6.56, P<0.001).
Wall-motion visualization results are provided in Figure
6. Six patients (20%) had no change in visualization
with contrast. The number of wall segments visualized
with contrast increased in 18 patients (60%), whereas
noncontrast echocardiograms yielded more visualized
walls in 6 patients (20%, P=0.002). Figures 1–4 and
Online Videos 1–8 demonstrate a benefit of contrast

Figure 5. Pie charts depicting percentage of total wall

segments (n=510) for which endocardial border was
visualized versus not visualized without and with the use
of contrast in patient echocardiograms.
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Figure 6. Bar graph of endocardial border visualization

with and without use of contrast in 30 patients. Each pair
of bars represents a patient with both their contrast image
readings and noncontrast image readings provided.

in a sample patient for whom all segments were
visualized with contrast compared to 8 segments
without contrast. A decrease in the number of wall
segments visualized with contrast was found in 6
patients (20%). Total visualization of all 17 segments
with contrast was seen in 18 patients (60%), whereas
total visualization without contrast occurred in
10 patients (33%).
Confidence Level
Of 30 contrast examinations, 17 were read at a High
confidence level. Figures 1–4 and Online Videos
1–8 provide an example in a sample patient. Of the
30 noncontrast examinations, 6 were read at a High
confidence level. Two-proportion Z-test comparing
High confidence readings with contrast to High
confidence readings without contrast administration
revealed a statistically significant improvement in these
readings (Z=2.92, P<0.001). A No confidence level
was recorded in 6 noncontrast studies, whereas a No
confidence level was not recorded in any contrast study.
Wall Segments
Of the 17 wall segments, those in the LV apex (wall
segments 14–17) were found to have the largest
increase in visualization with administration of contrast.
Contrast did not drastically change visualization of
the mid- and basal portions of the LV (wall segments
1–12). Figure 7 breaks down individual wall segments
to show how frequently each could be adequately
visualized on the 60 echocardiograms.
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invasive and costly examinations. Some patients’ heart
issues may be misdiagnosed.

Figure 7. Line graph of 17 wall segments visualized with
and without use of contrast in patient echocardiograms.

DISCUSSION

This research study explored the value of contrast
echocardiography in a high-volume echocardiography
laboratory. Significant improvement in endocardial
border definition as well as confidence of interpretation
was shown with the use of contrast, ultimately increasing
accuracy of the final echocardiography report. The
difference between contrast and noncontrast images in
defining endocardial borders was especially profound,
with an extreme Z score of 6.56. Our results reflect
previously published studies1,4,6,7,11-13 that concluded
contrast echocardiography contributes significant
value to the accuracy of diagnostic studies. We found
that using contrast significantly improved endocardial
definition over echocardiograms obtained without
contrast and provided quality diagnostic images in
echocardiography studies once considered suboptimal.
Interpretation of Endocardial Border and
Confidence Level Results
The American Society of Echocardiography’s
consensus statement on the clinical applications of
contrast agents notes that the accuracy of contrast
echocardiography in assessing LV function and
volumes has been validated and should be considered
in patients in whom precise information is clinically
required, such as those undergoing serial assessment of
LV function and those being evaluated for intracardiac
device placement.1 Valuable diagnostic and prognostic
information can be obtained with total visualization of
LV function.6 If echocardiograms are unable to fully
diagnose heart conditions, patients often require more
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Our findings provide additional evidence that contrast
increases visualization in a way that significantly boosts
even experienced cardiologists’ confidence when
interpreting echocardiographic tests. Our physicians’
confidence levels for their readings of endocardial
border definition were shown to significantly improve
with contrast use. A No confidence level was not
found in any of the 30 contrast studies, whereas 20%
of examinations without contrast were read at a No
confidence level. A No confidence level may indicate
an uninterpretable study.
Implications to the Field of Echocardiography
Many laboratories and hospitals are reluctant to use
contrast.7 This study demonstrates that use of contrast
echocardiography is important despite the potential
issues of cost, time, safety and misuse. Contrast agents
add extra cost to the echocardiogram and, because of
this, sonographers and physicians may be reluctant
to use it on all patients with suboptimal images, even
though studies have shown that the use of contrast is
cost-effective.6-8 Castello et al. determined that cost
savings can be achieved if use of contrast saved 10
minutes in echocardiography examination time for
patients in whom visualization without contrast was
difficult,7 and a cost-benefit analysis by Kurt et al. found
significant savings ($122/patient) from using contrast
in technically difficult patients.11 Moreover, physicians
may not need to order another costly examination
if crucial patient information is found on an initial
echocardiogram with contrast. A study demonstrating
the cost-effectiveness of contrast noted that 42% of
noncontrast echocardiograms indicated follow-up
testing compared to 12% of contrast echocardiograms.6
Critical and costly management decisions are based on
quantification of LV volumes and ejection fraction.2
Our study indicates that contrast can improve the
accuracy of these important quantifications and
could lessen the need for more costly examinations.
Echocardiography is a noninvasive study that has
the ability to provide physicians with important and
critical patient information. When contrast is not used
properly or when clinically indicated, patients may not
receive the most efficient and accurate diagnosis.
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There is a perception that contrast echocardiography
use takes more time to complete and therefore is
impractical in a high-volume laboratory. However,
Castello et al. and Lester et al. provided evidence that
contrast eliminates “struggle time” for sonographers.7,8
Our study was performed in a laboratory where the
sonographer did not have to delay the examination by
requesting physician approval to administer contrast.
Although data on contrast administration time were
not available for our retrospective study, our clinical
experience suggests it typically adds less than 15
minutes to total examination time. Contrast protocols
with a standing order for contrast use when clinically
indicated are important in reducing examination time.14
In 2007, the FDA issued a black box warning for two
perflutren-based microbubble contrast agents following
the deaths of four patients who were administered both
agents.15 This warning was issued even though there was
no significant evidence that their deaths were related
to either contrast agent,1 and despite the possibility
the deaths were caused by an existing condition, i.e.
a pseudocomplication.13 Nonetheless, this warning
sparked much disagreement regarding contrast use
in echocardiography laboratories across the country.
Because of this official warning, contraindications for
use of contrast agents were recommended for patients
with unstable cardiopulmonary status, including
patients with unstable angina, acute myocardial
infarction, respiratory failure or recent worsening
congestive heart failure. Bhatia et al. suggested that the
balance of risk to benefit needs to be considered with
each patient and that the benefits obtained with use of
contrast may outweigh the risks.6
Since the warning was issued, concern over the
contraindications among cardiologists led to the FDA
revising the labeling for contrast agents. The FDA’s
current prescribing information for Definity was
approved in May 2008, and includes a revised review
of the four patient deaths that supports causation by
possible pseudocomplication.13 Research has not shown
enough evidence to define any bioeffects from the
maximum-approved clinical injection dose of contrast
agents.1 Contrast is now only discouraged in patients
with known right-to-left shunts or a hypersensitivity
to perflutren.9 Although these contraindications have
been changed, some concern remains regarding
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contrast’s safety. While none of the patients in our
study experienced any safety issues or side effects with
use of contrast, the most common complaint in our
clinical experience is back pain that lasts a few minutes
and resolves once the agent has fully dissipated. Other
reported side effects for Definity –– including but not
limited to headache, nausea and prolonged Q-T interval
–– occur infrequently.16
Proper administration of contrast also is an issue
of debate. Contrast incorrectly administered by
sonographers and physicians may actually impede
examination quality to a level lower than that of
noncontrast examinations. In a test performed on an
80-year-old patient, the misuse of contrast displayed
a large atrial mass that was actually not there.17
Subsequent
transesophageal
echocardiography
allowed for the correct diagnosis. Artifacts induced
by contrast agents are caused by poor administration
and/or poor ultrasound machine mechanics, and can
severely degrade image quality.18 Attenuation occurs
when a higher concentration of contrast agents are
injected. The injection produces intense ultrasonic
backscatter, which precludes adequate interpretation of
the echocardiogram.19 This attenuation compromises
LV assessment by creating an acoustic shadowing
affect.18 Ultrasound technology has improved to help
correct these problems, but sonographers must use the
machine and contrast appropriately to avoid artifacts.
Every echocardiographic laboratory should have
a detailed written protocol for physicians, fellows
and sonographers to follow to administer contrast
correctly and to know when it is clinically indicated.
With continual advances in echocardiography, some
sonographers may be inadequately trained in the use
of contrast, possibly leading to nondiagnostic studies.20
The need for proper training and written protocols in
echocardiography laboratories is imperative.
Recommendations for Future Study
Our study produced tangential outcomes that could
be further studied. One such finding was that contrast
echocardiography proved most beneficial in particular
wall-segment locations. Visualization of the apical
LV segments significantly increased with use of
contrast, whereas the mid- and basal segments were
not. Hamilton-Craig et al. found similar results in
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their contrast study,21 which resulted in incomplete
endocardial definition for 11% of patients due to the
reduced definition of the basal myocardial segments.
This is a recognized phenomenon known as “basal
attenuation,” in which shadowing of basal segments is
seen due to a high concentration of contrast in the apical
blood pool near the ultrasound transducer,21 and may
explain why several noncontrast images of our patients
received superior grades to their contrast counterparts.
Future studies on why this is happening and what can be
done to aid visualization of the basal segments would be
beneficial to the field of echocardiography. Until then,
sonographers need to be aware of the complications
that may occur during contrast administration. We
recommend sonographers visualize basal segments as
clearly as possible prior to administration of contrast.
The combined effect may result in all segments
visualized in views with and without contrast, thereby
improving physician confidence level.
An unexpected finding was the differential results
observed
among
machine-contrast
packages.
Unfortunately, our sample size was not large enough
to truly signify which machine-contrast package
increased visualization and confidence the most, but
this could be a subject for future studies. Not only
would determining this aid in laboratories’ investment
plans, but it would also contribute information to
manufacturers about their products’ disadvantages and
advantages with contrast use.
Study Limitations
This study is limited by the respective availability of
microbubble contrast packages by four manufacturers.
Confidence level interpretation is subjective data and
open to bias, which may limit the accuracy of these
findings. However, the four reading physicians all
had Level III echocardiography training and clinical
experience in reading echocardiograms, which could
serve to minimize interobserver subjectivity.

CONCLUSIONS

This study further demonstrates the superiority
of contrast echocardiography for defining the
left ventricular endocardial border compared to
examinations without contrast. Yet, there are clinics
and hospitals in the United States and other countries
that are either not using contrast consistently or at all.
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It is beneficial for laboratories to establish a consistent
written protocol for the administration of contrast
echocardiography that includes proper technique,
explanation of machine mechanics and thorough
definition of indications for contrast use. Sonographers
should be trained in these skills and equipment.
Contrast agents are significantly valuable to the field
of echocardiography and their proper use should be
supported in inpatient and outpatient laboratories.
Patient-Friendly Recap
• Echocardiography, also known as ultrasound
imaging of the heart, is a diagnostic test that
reveals the heart’s structure and motion.
• Adding an intravenous contrast agent to improve
visual clarity is optional in many cases.
• The authors found that use of contrast
significantly helped highly trained echo
readers confidently interpret images.
• Echo laboratories should establish a written
protocol for the consistent use of contrast that
defines proper administration technique,
machine settings and indications.
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